This image is not available for purchase in your country.

Immunotherapy for cancer using Interleukin-2

Immunotherapy for cancer using Interleukin-2

G442/0013

Rights Managed

This image is not available for purchase in your country.

Please contact your Account Manager if you have any query.

Credit

PHILIPPE PLAILLY / SCIENCE PHOTO LIBRARY PHILIPPE PLAILLY / SCIENCE PHOTO LIBRARY

Caption

Immunotherapy for cancer: scientist examining wells containing cell cultures of lymphocytes that have been doped with Interleukin-2 (IL-2) for possible contamination. IL-2 is released naturally by certain key cells of the immune system (T- lymphocytes) after they have been activated by foreign antigens - of cancer cells, for instance. IL-2 amplifies the proliferation of other cell types, including lymphokine-activated natural killer (LANAK) cells that attack cancer cells directly. In this technique, blood is removed, doped with IL-2 & cultured in vitro for 3-4 weeks to raise the population of LANAK cells. The product is then re-injected into the patient. Photographed at Institut Gustave Roussy, Villejuif, France, 1988/89.

Release details

Model release not available. Property release not required.

 {{ i.shot_duration ? i.shot_duration + ' ' : '' }}{{ i.shot_uhd ? '4K ' : i.hires ? 'HD ' : '' }}{{ i.spl_number }} R{{ i.license }}

  • Add to board
  • Similar {{ mediaType(i) }}